FrancophonIA/ELRC3.0 huggingface dataset:
English: The Committee considered that the risk of hypersensitivity is increased in patients with known allergies (including drug allergies) and in patients with immune or inflammatory conditions (e.g. systemic lupus erythematosus, rheumatoid arthritis) as well as in patients with a history of severe asthma, eczema or other atopic allergy.
Danish: • udvalget fandt, at risikoen for hypersensitivitet er øget hos patienter med kendte allergier (herunder lægemiddelallergi) og hos patienter med immunbetingede eller inflammatoriske sygdomme (f.eks. systemisk lupus erythematosus, reumatoid arthritis) eller med anamnese med svær astma, eksem eller anden atopisk allergi.
English: Furthermore the PRAC requested that the protocol of a Post-Authorisation Safety Study (PASS) should be submitted within the risk management plan submission, to better characterize the safety concerns for the hypersensitivity reactions.
Danish: Desuden anmodede PRAC om, at der sammen med indsendelse af risikostyringsplanen forelægges en protokol til en sikkerhedsundersøgelse efter markedsføring (PASS) til nærmere karakterisering af sikkerhedsproblemerne i forbindelse med hypersensitivitetsreaktionerne.
English: Furthermore the CHMP requested that a PASS will be conducted to further evaluate the safety concern of the hypersensitivity reactions, as well as adequate educational materials to be developed for patients and prescribers.
Danish: CHMP anmodede desuden om, at der udføres en PASS til nærmere vurdering af sikkerhedsproblemer med hypersensitivitetsreaktioner, og at der udarbejdes passende informationsmateriale til patienter og ordinerende læger,
English: Pregnant women were among the cases with hypersensitivity reactions.
Danish: Tilfælde af hypersensitivitetsreaktioner forekom også hos gravide kvinder.
English: For pregnancy specifically, as oral iron may be well tolerated in the first trimester of the pregnancy, the CHMP advised that the intravenous iron complexes are not given to pregnant women in the early stages.
Danish: Specielt for graviditet anbefalede CHMP, at intravenøst administrerede jernkomplekser ikke gives til kvinder i de tidlige stadier af graviditeten, da orale jernpræparater kan være veltolererede i første trimester.
English: The MAHs also should amend their risk management plan, provide a protocol of a PASS within the risk management plan submission to characterise the safety concerns on the hypersensitivity reactions and also provide educational material for prescribers and patients.
Danish: Indehaverne af markedsføringstilladelsen skal derudover ændre deres risikostyringsplan, i risikostyringsplanen forelægge protokol til en PASS til karakterisering af sikkerhedsproblemerne ved hypersensitivitetsreaktioner og desuden udlevere oplysningsmateriale til ordinerende læger og patienter.
English: In inflammatory bowel disease population, according to Khalil et al (2011), 6% of IBD patients experienced anaphylactoid reactions (Ring and Messmer grade I-II).
Danish: I en population med inflammatorisk tarmsygdom fik 6 % af patienterne anafylaktoide reaktioner, Ring og Messmer grad I-II (Khalil et al, 2011).
English: In iron deficiency anaemia there were three publications with no anaphylactoid reactions reported.
Danish: Der var tre publikationer vedrørende jernmangelanæmi, og ingen af disse omtalte anafylaktoide reaktioner.
English: The frequency of hypersensitivity related events reported with iron sucrose in the analysed clinical trials (0.27%) was considerably less than the hypersensitivity event risk for the respective background populations (1.2
Danish: Hyppigheden af hypersensitivitetsrelaterede hændelser med jernsukrose (0,27 %) i de analyserede kliniske undersøgelser var væsentligt lavere end risikoen for hypersensitivitetshændelser i de pågældende baggrundspopulationer (1,2-16,8 %).
English: Only the cases in which sodium ferric gluconate was given parenterally were taken into account.
Danish: Analysen omfatter kun de tilfælde, hvor natriumferrigluconat blev indgivet parenteralt.
English: The vast majority of these concerned patients in chronic kidney disease (CKD) and treatment in patients undergoing chronic haemodialysis (HD).
Danish: Den overvejende del af dem vedrørte patienter med kronisk nyresygdom og behandling af patienter i kronisk hæmodialyse.
English: The Committee considered that in view of the currently available safety data in order to maintain a favourable benefit-risk balance, these intravenous iron containing medicinal products should be contraindicated in patients with history of hypersensitivity reactions to the active substance or any of the excipients of these products, as well as to patients who experienced allergic reactions to other parenteral iron containing products.
Danish: • udvalget fandt, at i betragtning af de på nuværende tidspunkt tilgængelige sikkerhedsdata og for at opretholde et gunstigt benefit/risk-forhold bør sådanne intravenøst administrerede jernholdige lægemidler være kontraindiceret, når der i anamnesen er hypersensitivitet eller reaktioner over for det aktive indholdsstof eller nogen af hjælpestofferne eller tidligere allergisk reaktion over for andre parenterale jernholdige produkter.
English: In addition the CHMP requested the MAHs to submit annual cumulative reviews of hypersensitivity case reports, all fatal cases and all pregnancy cases, together with usage data yearly.
Danish: Desuden anmodede CHMP indehaverne af markedsføringstilladelsen om årligt at indsende en samlet gennemgang af hypersensitivitetsindberetninger, alle dødelige tilfælde og alle tilfælde af graviditet, samt oplysninger om lægemiddelanvendelse.
English: No consistent pattern or predictive dose appears and the higher individual doses do not appear to be correlated with increased frequency or severity of events.
Danish: Der ses intet sammenhængende mønster eller nogen forudsigelig dosis, og højere enkeltdoser synes ikke at være korreleret med øget bivirkningsfrekvens eller -sværhed.
English: However the discussion of the existing preclinical data did not clear the immunogenic point, therefore the existing pre-clinical data do not allow for any firm conclusions; the CHMP conclusions were reached based on clinical and pharmacovigilance data.
Danish: De foreliggende prækliniske data førte imidlertid ikke til afklaring af punktet immunogenicitet og gav derfor ikke mulighed for at drage endelige konklusioner.
English: The CHMP concluded that the benefit-risk balance of intravenous iron containing medicinal products is favourable as the benefits continue to outweigh the risks in the treatment of iron deficiency when the oral route is insufficient or poorly tolerated.
Danish: CHMP konkluderede, at benefit/risk-forholdet for intravenøst administrerede jernholdige lægemidler er gunstigt, da fordelene fortsat overstiger risiciene til behandling af jernmangel, når oral administration er utilstrækkelig eller ikke tolereres.
English: Cumulative annual reporting of hypersensitivity reactions should be undertaken by all MAHs of these products.
Danish: Alle indehavere af markedsføringstilladelse for disse produkter skal årligt indsende kumulative indberetninger om hypersensitivitetsreaktioner.
English: In addition in vitro reactivity of various marketed intravenous iron preparations towards anti-dextran antibodies was tested in a reverse radial immunodiffusion assays.
Danish: Lancet intravenøst administrerede jernholdige præparater over for anti-dextranantistoffer bestemt ved omvendt radial immundiffusion.
English: A total of 13,134 patients have been included in 29 MAH sponsored Phase 1 to 3 studies in different therapeutic areas (nephrology, gynaecology, gastroenterology, neurology, cardiology and iron deficiency anaemia), of which 6,608 have received ferric carboxymaltose and compared with those receiving other parenteral irons.
Danish: Der er i alt inkluderet 13 134 patienter i 29 fase 1- til 3-undersøgelser, der var sponsoreret af indehaveren af markedsføringstilladelsen og omfattede forskellige behandlingsområder (nefrologi, gynækologi, gastroenterologi, neurologi, kardiologi og jernmangelanæmi).
English: There does not appear to be a consistent pattern or predictive dose or rate of infusion that relates to the chance of these events occurring and importantly the higher individual doses do not appear to be correlated with increased frequency or severity of events.
Danish: Der ser ikke ud til at være noget ensartet mønster eller nogen forudsigelig dosis eller infusionshastighed, der har sammenhæng med risikoen for indtræden af disse bivirkninger, og vigtigt ser højere enkeltdoser ikke ud til at være korreleret med øget bivirkningsfrekvens eller -sværhed.
English: Iron gluconate (sodium ferric gluconate)
Danish: Jerngluconat (natriumferrigluconat)
English: For ferric carboxymaltose as well as iron sucrose in animal studies in guinea pigs that had been administered immune serum containing iron-dextran antibodies, a clear skin reaction after the administration of dextran was observed (positive control).
Danish: Både for jerncarboxymaltose og jernsukrose sås en klar hudreaktion efter administration af dextran (positiv kontrol) til marsvin, der havde fået indgivet immunserum indeholdende jerndextran-antistoffer.
English: Finally educational material for prescribers as well for patients highlighting the risks and warnings of hypersensitivity reactions (by e.g. a checklist, to be implemented at national level) have been requested by the CHMP for submission within the risk management plan.
Danish: Endelig anmodede CHMP om, at der som en del af risikostyringsplanen forelægges oplysningsmateriale til både ordinerende læger og patienter, hvor risici og advarsler vedrørende hypersensitivitetsreaktioner fremhæves (f.eks. gennem en tjekliste, der indføres på nationalt plan).
English: Sodium ferric gluconate
Danish: Natriumferrigluconat
English: The Committee concluded that the benefit-risk balance of intravenous iron containing medicinal products in the iron deficiency situations where the oral iron is not sufficient or tolerated remains positive under normal conditions of use, subject to the restrictions, warnings, changes to the product information, additional pharmacovigilance activities and risk minimisation measures agreed.
Danish: Udvalget konkluderede, at i jernmangelsituationer, hvor oralt jern ikke er tilstrækkeligt eller ikke er veltolereret, er benefit/risk-forholdet for intravenøst administrerede jernholdige lægemidler fortsat positivt under normale anvendelsesbetingelser under forudsætning af de vedtagne betingelser, advarsler og ændringer i produktinformationen og de vedtagne supplerende lægemiddelovervågningsog risikominimeringsforanstaltninger.
English: The CHMP reviewed all available data from pre-clinical and clinical studies, published literature and post-marketing experience on the hypersensitivity reactions of intravenous iron containing medicinal products.
Danish: CHMP gennemgik alle foreliggende data fra prækliniske og kliniske undersøgelser, den publicerede litteratur og erfaringer efter markedsføring vedrørende hypersensitivitetsreaktioner over for intravenøst administrerede jernholdige lægemidler.
English: The Committee as consequence concluded that the benefit-risk balance of intravenous iron containing medicinal products in the iron deficiency situations where the oral iron is not sufficient or tolerated remains positive under normal conditions of use, subject to the restrictions, warnings, changes to the product information, additional pharmacovigilance activities and risk minimisation measures agreed.
Danish: konkluderede udvalget, at i jernmangelsituationer, hvor oralt jern ikke er tilstrækkeligt eller ikke er veltolereret, er benefit/risk-forholdet for intravenøst administrerede jernholdige lægemidler fortsat positivt under normale anvendelsesbetingelser under forudsætning af de vedtagne betingelser, advarsler og ændringer i produktinformationen og de vedtagne supplerende lægemiddelovervågningsog risikominimeringsforanstaltninger.
English: This supports the conclusion that in patients with known allergies and with immune or inflammatory conditions (e.g. systemic lupus erythematosus, rheumatoid arthritis) the risk of hypersensitivity reactions is enhanced.
Danish: Dette støtter konklusionen om, at risikoen for hypersensitivitetsreaktioner er forhøjet hos patienter med kendt allergi og immunbetingede eller inflammatoriske sygdomme (f.eks. systemisk lupus erythematosus, reumatoid arthritis).
English: There is no consistent pattern or predictive dose or administration relationship in relation with the occurrence of these events and importantly the higher individual doses do not appear to be correlated with increased frequency or severity of events.
Danish: Hændelserne synes ikke at have noget ensartet mønster, nogen sammenhæng med en forudsigelig dosis eller med administrationen, og vigtigt ser højere enkeltdoser ikke ud til at være korreleret med øget bivirkningsfrekvens eller -sværhed.
English: The Committee reviewed all available data from pre-clinical, clinical studies, published literature, postmarketing experience on the safety of intravenous iron containing medicinal products with regards to hypersensitivity reactions.
Danish: Udvalget gennemgik alle foreliggende data fra prækliniske og kliniske undersøgelser, den publicerede litteratur og erfaringer efter markedsføring om sikkerheden af intravenøst administrerede jernholdige lægemidler hvad angår hypersensitivitetsreaktioner.
English: The Committee reviewed all available data from pre-clinical, clinical studies, pharmacoepidemiological studies, published literature, post-marketing experience on the safety of intravenous iron containing medicinal products with regards to hypersensitivity reactions.
Danish: • udvalget gennemgik alle foreliggende data fra prækliniske og kliniske undersøgelser, farmakoepidemiologiske undersøgelser, den publicerede litteratur og erfaringer efter markedsføring om sikkerheden ved intravenøst administrerede jernholdige lægemidler med henblik på hypersensitivitetsreaktioner,
English: The Committee is of the opinion that the benefits of intravenous iron containing medicinal products continue to outweigh the risks in the treatment of iron deficiency situations when the oral route is insufficient or poorly tolerated.
Danish: • udvalget er af den opfattelse, at benefit/risk-forholdet for intravenøst administrerede jernholdige lægemidler er gunstigt, da fordelene fortsat overstiger risiciene til behandling af jernmangel, når oral administration er utilstrækkelig eller ikke tolereres,
English: Of these, 17 were considered serious, of which five within the immune system disorder, as mentioned above.
Danish: Som konklusion er der indgået 26 spontane indberetninger med jern(III)-isomaltosid 1000, hvoraf 17 blev anset for alvorlige, af hvilke 5 som nævnt vedrørte immunsystemet.
English: Iron sucrose
Danish: Jernsukrose
English: Xofigo was authorised in the European Union in November 2013.
Danish: Xofigo blev godkendt i Den Europæiske Union i november 2013.
English: 19 March 2018 EMA/176752/2018
Danish: 19. marts 2018 EMA/220001/2018
English: The review of Xofigo has been initiated at the request of the European Commission, under Article 20 of Regulation (EC) No 726/2004.
Danish: Gennemgangen af Xofigo er blevet iværksat på anmodning af Europa-Kommissionen i henhold til artikel 20 i forordning (EF) nr. 726/2004.
English: • If you are being treated with this combination, your doctor will alter your treatment.
Danish: • Hvis du er i behandling med denne kombination, vil din læge ændre din behandling.
English: • If you are being treated with Xofigo and have any questions, you should contact your doctor.
Danish: • Hvis du bliver behandlet med Xofigo og har spørgsmål, bør du kontakte din læge.
English: More information on Xofigo is available.
Danish: Der findes yderligere oplysninger om Xofigo.
English: The final stage of the review procedure is the adoption by the European Commission of a legally binding decision applicable in all EU Member States.
Danish: Det sidste trin i gennemgangsproceduren er Europa-Kommissionens vedtagelse af en retligt bindende afgørelse med gyldighed i alle EU's medlemsstater.
English: Ongoing clinical study shows increased risk of death and fractures with the combination
Danish: Igangværende klinisk undersøgelse påviser øget risiko for dødsfald og frakturer ved denne kombination
English: These are temporary measures until the ongoing in-depth review of the benefits and risks of Xofigo is complete.
Danish: Dette er midlertidige foranstaltninger, der er gældende, indtil den igangværende grundige gennemgang af fordele og risici ved Xofigo er udført.
English: During the review, the PRAC made provisional recommendations to protect public health.
Danish: PRAC udstedte under gennemgangen en række foreløbige anbefalinger for at beskytte folkesundheden.
English: This was sent to the European Commission (EC), which issued a provisional legally binding decision on 19 March
Danish: Disse anbefalinger blev fremsendt til Europa-Kommissionen, der vedtog en midlertidig og retligt bindende afgørelse for hele EU den 19. marts 2018.
English: Fractures have also occurred more frequently with the Xofigo combination than the placebo combination (26% versus 8.1%).
Danish: Der er også observeret en hyppigere frekvens af frakturer med Xofigo-kombinationen end med placebokombinationen (26 % vs. 8,1 %).
English: EMA's Pharmacovigilance Risk Assessment Committee (PRAC) had reviewed the preliminary data from an ongoing clinical study in metastatic prostate cancer patients.
Danish: EMA's Udvalg for Risikovurdering inden for Lægemiddelovervågning (PRAC) havde gennemgået de foreløbige data fra en igangværende klinisk undersøgelse hos patienter med metastatisk prostatakræft.
English: • Further information will be made available once an ongoing review of the evidence is complete.
Danish: • Så snart den igangværende gennemgang af dataene er afsluttet, vil der blive fremlagt yderligere oplysninger.
English: In view of the seriousness of the events reported, the PRAC took action by introducing a contraindication as a temporary measure to protect patients' safety while an in-depth review of the benefits and risks of Xofigo is ongoing.
Danish: Som følge af den alvorlige karakter af de indberettede hændelser har PRAC indført en kontraindikation som en midlertidig foranstaltning for at beskytte patienternes sikkerhed, mens der foretages en grundig gennemgang af fordelene og risiciene ved Xofigo.
English: Once the PRAC review is concluded, its recommendations will be forwarded to the Committee for Medicinal Products for Human Use (CHMP), responsible for evaluating medicines for human use, which will adopt a final opinion.
Danish: Når PRAC har afsluttet gennemgangen, vil udvalgets anbefalinger blive sendt til Udvalget for Lægemidler til Mennesker (CHMP), der er ansvarligt for at evaluere lægemidler til mennesker, og som vil træffe en endelig afgørelse.
English: The review is being carried out by the Pharmacovigilance Risk Assessment Committee (PRAC), the Committee responsible for the evaluation of safety issues for human medicines, which will make a set of recommendations.
Danish: Gennemgangen foretages af Udvalget for Risikovurdering inden for Lægemiddelovervågning (PRAC), som har ansvar for vurdering af sikkerhedsspørgsmål vedrørende lægemidler til mennesker, og som vil fremsætte en række anbefalinger.
English: It is authorised for use when medical or surgical castration (stopping the production of male hormones in the body using medicines or surgery) does not work, and when the cancer has spread to the bones and is causing symptoms such as pain but is not known to have spread to other internal organs.
Danish: Det er godkendt til brug, når medicinsk eller kirurgisk kastration (standsning af produktionen af mandlige kønshormoner i kroppen enten med lægemidler eller ved operation) ikke virker, og når kræften har spredt sig til knoglerne og giver symptomer såsom smerter, men ikke har bredt sig til andre indre organer.
English: In this study 34.7% of patients treated with Xofigo, Zytiga and prednisone/prednisolone have died so far, compared with 28.2% of patients given placebo, Zytiga and prednisone/prednisolone.
Danish: Indtil videre er 34,7 % af de patienter i studiet, der fik Xofigo, Zytiga og prednison/prednisolon, døde, sammenholdt med 28,2 % af de patienter, der fik placebo, Zytiga og prednison/prednisolon.
English: Patients have completed the Xofigo part of the study, and the combination is no longer being used; all the patients involved are being monitored closely.
Danish: Patienterne har gennemført Xofigo-delen af undersøgelsen, og kombinationen bruges ikke længere.
English: Xofigo is currently authorised for use in men whose prostate cancer has spread to the bones and is causing symptoms.
Danish: Xofigo er i øjeblikket godkendt til brug hos mænd, hvis prostatakræft har spredt sig til knoglerne og medført symptomer.
English: On 8 March 2018, the European Medicines Agency (EMA) recommended contraindicating the use of the prostate cancer medicine Xofigo (radium-223 dichloride) with Zytiga (abiraterone acetate) and prednisone/prednisolone, due to an increased risk of death and fractures with this combination.
Danish: Den 8. marts 2018 anbefalede Det Europæiske Lægemiddelagentur (EMA) at kontraindicere brugen af lægemidlet mod prostatakræft Xofigo (radium-223 dichlorid) sammen med Zytiga (abirateronacetat) og prednison/prednisolon på grund af en øget risiko for dødsfald og frakturer ved denne kombination.
English: The ongoing clinical study includes metastatic prostate cancer patients who have not previously received chemotherapy and who have no symptoms or only mild symptoms, such as pain.
Danish: Det igangværende kliniske studie omfatter patienter med metastatisk prostatakræft, der ikke tidligere har fået kemoterapi, og som ingen symptomer har eller kun har milde symptomer, f.eks. smerter.
English: • The safety and efficacy of Xofigo in combination with second generation androgen receptor antagonists such as Xtandi (enzalutamide) have not been established.
Danish: • Sikkerheden og virkningen ved Xofigo i kombination med andengenerations-androgenreceptorantagonister, som f.eks. Xtandi (enzalutamid), er ikke klarlagt.
English: EMA will communicate further at the conclusion of the review.
Danish: Når gennemgangen er afsluttet, vil EMA komme med yderligere oplysninger.
English: Healthcare professionals are also warned that the safety and efficacy of Xofigo in combination with a class of medicines called second generation androgen receptor antagonists, such as Xtandi (enzalutamide), have not been established.
Danish: Sundhedspersoner advares også om, at sikkerheden og virkningen ved Xofigo i kombination med såkaldte andengenerationsandrogenreceptor-antagonister, f.eks. Xtandi (enzalutamid), ikke er klarlagt.
English: The ongoing study of Xofigo in combination with Zytiga and prednisone/prednisolone included patients with castration-resistant prostate cancer that has spread mainly to the bones, who have no symptoms or only mild symptoms and who have not been treated with chemotherapy.
Danish: Det igangværende studie af Xofigo i kombination med Zytiga og prednison/prednisolon omfatter patienter, som har kastrationsresistent prostatakræft, der har spredt sig primært til knoglerne, som har ingen eller kun milde symptomer, og som ikke tidligere er blevet behandlet med kemoterapi.
English: • Xofigo must not be used with the anti-androgen Zytiga (abiraterone acetate) and prednisone/prednisolone because of possible increased risk of fractures and mortality.
Danish: • Xofigo må ikke anvendes sammen med antiandrogenet Zytiga (abirateronacetat) og prednison/prednisolon på grund af en mulig øget risiko for frakturer og dødsfald.